Franklin Biotechnology Discovery Fund Probability of Future Mutual Fund Price Finishing Under 145.38
| FRBRX Fund | USD 149.43 1.43 0.97% |
Franklin |
Franklin Biotechnology Target Price Odds to finish below 145.38
The tendency of Franklin Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 145.38 or more in 90 days |
| 149.43 | 90 days | 145.38 | near 1 |
Based on a normal probability distribution, the odds of Franklin Biotechnology to drop to $ 145.38 or more in 90 days from now is near 1 (This Franklin Biotechnology Discovery probability density function shows the probability of Franklin Mutual Fund to fall within a particular range of prices over 90 days) . Probability of Franklin Biotechnology price to stay between $ 145.38 and its current price of $149.43 at the end of the 90-day period is under 4.
Assuming the 90 days horizon the mutual fund has the beta coefficient of 1.06 . This usually indicates Franklin Biotechnology Discovery market returns are sensitive to returns on the market. As the market goes up or down, Franklin Biotechnology is expected to follow. Additionally Franklin Biotechnology Discovery has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Franklin Biotechnology Price Density |
| Price |
Predictive Modules for Franklin Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Franklin Biotechnology. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Franklin Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Franklin Biotechnology is not an exception. The market had few large corrections towards the Franklin Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Franklin Biotechnology Discovery, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Franklin Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | 1.06 | |
σ | Overall volatility | 4.26 | |
Ir | Information ratio | -0.18 |
Franklin Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Franklin Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Franklin Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Franklin Biotechnology generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Franklin Biotechnology Discovery Fund Q3 2024 Commentary - Seeking Alpha | |
| The fund retains 98.75% of its assets under management (AUM) in equities |
Franklin Biotechnology Technical Analysis
Franklin Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Franklin Mutual Fund technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Franklin Biotechnology Discovery. In general, you should focus on analyzing Franklin Mutual Fund price patterns and their correlations with different microeconomic environments and drivers.
Franklin Biotechnology Predictive Forecast Models
Franklin Biotechnology's time-series forecasting models is one of many Franklin Biotechnology's mutual fund analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Franklin Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the mutual fund market movement and maximize returns from investment trading.
Things to note about Franklin Biotechnology
Checking the ongoing alerts about Franklin Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Franklin Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Franklin Biotechnology generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Franklin Biotechnology Discovery Fund Q3 2024 Commentary - Seeking Alpha | |
| The fund retains 98.75% of its assets under management (AUM) in equities |
Other Information on Investing in Franklin Mutual Fund
Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |